Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) can induce long-term remissions in patients with chronic lymphocytic leukemia. Treatment efficacy with Bruton's tyrosine kinase inhibitors was found similar to FCR in untreated chronic lymphocytic leukemia patients with a...
Saved in:
Published in | Haematologica (Roma) Vol. 107; no. 3; pp. 615 - 624 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Fondazione Ferrata Storti
01.03.2022
Ferrata Storti Foundation |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!